| |
|
|
|
|
|
|
|||
|
Blood, 1 April 2004, Vol. 103, No. 7, pp. 2705-2709. Prepublished online as a Blood First Edition Paper on December 4, 2003; DOI 10.1182/blood-2003-10-3552.
Submitted October 17, 2003
Department of Laboratory Medicine and Pathobiology, St. Michael's Hospital, Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada; Canadian Blood Services, Toronto, ON, Canada * Corresponding author; email: semplej{at}smh.toronto.on.ca.
The mechanisms responsible for IgG immunity against allogeneic platelets are poorly understood. We studied the role that murine recipient CD8+ T and natural killer (NK) cells play in immunity against allogeneic platelets. BALB/c mice were depleted of the cells by cell-specific antibodies, transfused weekly with platelets from C57BL/6 mice and serum IgG antidonor antibodies were measured by flow cytometry. While allogeneic platelet transfusions into wild type recipients stimulated IgG antidonor antibodies in all mice by the fifth transfusion, CD8-depleted mice had significantly (p<0.001) enhanced antibody production. Isotype analysis revealed that CD8+ T cells suppressed Th2-associated IgG1 but enhanced Th1-associated IgG2a. Compared with wild type mice, platelet transfusions into CD8-depleted mice stimulated enhanced intracellular interferon (IFN)-
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2003 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||